Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02646319
Title Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Mayo Clinic

cervical squamous cell carcinoma

renal cell carcinoma

breast cancer

uterine cancer

Advanced Solid Tumor

urinary bladder cancer

head and neck cancer

ovarian cancer

endometrial cancer



Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST